Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × belzutifan × Clear all

Phase

Status

Active not recruiting 4 Recruiting 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Paclitaxel 257 Cisplatin 233 Gemcitabine 229 Carboplatin 221 Cyclophosphamide 201 Radiotherapy 197 Irinotecan 166 Bevacizumab 153 pembrolizumab 148 Docetaxel 148 Capecitabine 132 Nivolumab 127 Fluorouracil 117 Dexamethasone 111 Bortezomib 109 Erlotinib Hydrochloride 107 Oxaliplatin 105 Sorafenib 103 Cytarabine 103 Temozolomide 97 Rituximab 96 Leucovorin 95 Doxorubicin 95 Etoposide 94 Filgrastim 93 Lenalidomide 86 Everolimus 85 Pemetrexed 81 Ipilimumab 78 fludarabine phosphate 74

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04627064 2025-07-25

ABEMA Alone or in COMBO With MK-6482

Dana-Farber Cancer Institute

Phase 1 Completed

11 enrolled 9 charts

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡